Netherlands· NL-091102b9a3b6

Axura 5 mg +10 mg +15 mg + 20 mg filmomhulde tablet

A memantine product containing memantinehydrochloride + memantinehydrochloride + memantinehydrochloride + memantinehydrochloride, registered in Netherlands by Merz Pharmaceuticals GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC N06DX01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about memantinehydrochloride + memantinehydrochloride + memantinehydrochloride + memantinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Memantine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search memantine products by name

Memantine · ATC N06DX01

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of memantine costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Memantine · price per daily dose (20 mg)

USD · FX 28 Sept 2026

ES Spain$2.93
CH Switzerland$2.47
IT Italy$0.77
US United States$0.22 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MEMANTINEHYDROCHLORIDE + MEMANTINEHYDROCHLORIDE + MEMANTINEHYDROCHLORIDE + MEMANTINEHYDROCHLORIDE
Manufacturer: Merz Pharmaceuticals GmbH
Country: Netherlands (NL)
ATC code: N06DX01
ATC class: Memantine
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/02/218

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

139 interactions on record for memantine.

Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check memantine against other medicines How interaction checks work

Memantine · interactions on record

139 records

42 moderate
11 minor
80 info

Most severe, free to view

DicycloverineA03AA07moderate
PropanthelineA03AB05moderate
MepenzolateA03AB12moderate
TrospiumA03AB20moderate

6 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Memantine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All memantine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Alsemora, Memantin 1a Pharma
Belgium · Alsemora, Memantine Eg
Bulgaria · Memantine Grindeks, Имана
Cyprus · Alzedem, Mantomed
Czechia · Cognomem, Mantomed
Germany · Alsemora, Memantin
Denmark · Alsemora, Marbodin
Estonia · Alsemora, Mantomed
Spain · Alsemora, Mantinex
Finland · Alsemora, Marbodin
France · Alsemora, Memantine Arrow Lab
United Kingdom (Northern Ireland) · Memantine, Memantine Dawa
Greece · Almerzac, Alsemora
Croatia · Alsemora, Mantomed
Hungary · Memantin Goodwill, Memantin Stada
Ireland · Memantine Clonmel, Memantine Grindeks
Iceland · Axura, Ebixa
Italy · Demenco, Ezemantis
Liechtenstein · Axura, Memantine Accord
Lithuania · Alsemora, Maryzola
Luxembourg · Memantine Eg
Latvia · Alsemora, Mantomed
Malta · Memantine Aurobindo, Memantine Clonmel
Norway · Alsemora, Axura
Poland · Auromemo, Biomentin
Portugal · Alsemora, Mantinex
Romania · Alsemora, Memantina Atb
Sweden · Alsemora, Marbodin
Slovenia · Alsemora, Mantomed
Slovakia · Alsemora, Mantomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c1758721-b89f-4f4a-b11b-bf0e69a6a03c
GET /v1/drugs/c1758721-b89f-4f4a-b11b-bf0e69a6a03c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/axura-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Memantine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp100896",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 400",
    "MACROGOL 400",
    "MACROGOL 400",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "MEMANTINEHYDROCHLORIDE",
    "MEMANTINEHYDROCHLORIDE",
    "MEMANTINEHYDROCHLORIDE",
    "MEMANTINEHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2008/05/08",
  "procedure_number": "EMEA/H/C/000378",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/02/218",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about memantine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console